The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so things like tnf-alpha which is the target of the most successful drug in the world today you know you Myra then it's an anti-tnf drug you see a factors like veg F alpha the target of things like Lucentis and Ilia multi multi-billion dollar drugs for the treatment of diseases of the eye and also using cancer
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.